Report of SARS-CoV-2 JN.1 variant in Morocco-Reference-Cited by-同舟云学术

Report of SARS-CoV-2 JN.1 variant in Morocco

Published:2024-09-10 Issue:9 Volume:13 Page:
ISSN:2576-098X
Container-title:Microbiology Resource Announcements
language:en
Short-container-title:Microbiol Resour Announc

Author:

Bouddahab Oumaima¹²,El Hamouchi Adil³,Aqillouch Safaa¹^ORCID,Charoute Hicham⁴,Noureddine Rachid⁵,Aainouss Achraf⁵,Baba Hanâ¹,Ouladlahsen Ahd⁶,Nourlil Jalal⁷,Sarih M'hammed⁸,Maaroufi Abderrahmane¹,Lkhider Mustapha²,Barakat Abdelhamid⁹,Ezzikouri Sayeh¹^ORCID

Affiliation:

1. Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco

2. Laboratory of Virology, Microbiology, Quality and Biotechnology/Ecotoxicology and Biodiversity, Faculty of Sciences and Techniques of Mohammedia, Hassan II University of Casablanca, Mohammedia, Morocco

3. Centre de Séquençage Génomique, Institut Pasteur du Maroc, Casablanca, Morocco

4. Research Unit of Epidemiology, Biostatistics and Bioinformatics, Institut Pasteur du Maroc, Casablanca, Morocco

5. Laboratoire Morizgo d’Analyses Médicales, Casablanca, Morocco

6. Service des Maladies Infectieuses, CHU Ibn Rochd, Casablanca, Morocco

7. Medical Virology and BSL3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco

8. Service de Parasitologie et des Maladies Vectorielles, Institut Pasteur du Maroc, Casablanca, Morocco

9. Laboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca, Morocco

Abstract

ABSTRACT In this study, we report the identification of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) JN.1 variant and the quasi-complete genomic sequencing of four clinical samples in Morocco. Nasopharyngeal swabs were obtained from four patients (one female, three males). The Illumina COVIDSeq Test was used for comprehensive genomic analysis.

Funder

Action Concertées Interpasteuriennes

AFRICA CDC

Publisher

American Society for Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mra.00559-24

Reference5 articles.

1. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike

2. Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant

3. Virological characteristics of the SARS-CoV-2 JN.1 variant

4. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure

5. An early warning system for emerging SARS-CoV-2 variants